Drug Use Investigation of Somatropin for GHD-ADULTS.

Pfizer

Status: Completed

Conditions: Dwarfism, Growth Hormone Deficiency

Treatments: Drug: Somatropin

Study type: Observational

Funder types: Industry

Identifiers

NCT00601419

A6281286

Details and patient eligibility

About

Post marketing drug use investigation of Genotropin for GHD-ADULTS.

Full description

All the patients whom an investigator prescribes the first Somatropin should be registered consecutively until the number of subjects reaches target number.

Enrollment: 230 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

The patients who were administered Somatropin to treat "Adult growth hormone deficiency (limited to severe type)".

Exclusion criteria

Patients not administered Somatropin.

Trial design

230 participants in 1 patient group

Somatropin

Description:

Patients administered Somatropin.

Treatment:

Drug: Somatropin